Orosz C G, Adams P W, Ferguson R M
Transplantation. 1987 May;43(5):718-24.
Quantitative immunologic techniques for analysis of human alloreactivity are currently lacking in transplantation immunology. We report a rapid, sensitive, and quantitative limiting dilution analysis technique that provides a minimal estimate of the number of peripheral blood mononuclear cells (PBMC) capable of secreting interleukin-2 (operationally defined as helpter T lymphocytes) when cultured in vitro with allogeneic PBMC bearing serologically identified MHC disparities. Using this LDA technique, we have estimated that approximately 1/500 to 1/2000 (0.2% to 0.05%) of the PBMC from various individuals can secrete IL-2 after in vitro contact with completely major-histocompatibility-complex-disparate PBMC. Under normal conditions the HTL frequency in human peripheral blood appears quite stable, based on serial analysis of HTL frequency in a healthy human donor. This LDA technique is more rapid and informative than the MLR, and may be useful for pretransplant evaluation and posttransplant monitoring of donor reactivity in transplant recipients.
目前移植免疫学中缺乏用于分析人类同种异体反应性的定量免疫技术。我们报告了一种快速、灵敏且定量的极限稀释分析技术,该技术能对在外体与带有血清学鉴定的MHC差异的同种异体外周血单个核细胞(PBMC)共培养时能够分泌白细胞介素-2的外周血单个核细胞(操作上定义为辅助性T淋巴细胞)数量提供最小估计值。使用这种极限稀释分析(LDA)技术,我们估计,来自不同个体的PBMC在与完全主要组织相容性复合体不匹配的PBMC进行体外接触后,约1/500至1/2000(0.2%至0.05%)能够分泌IL-2。基于对一名健康人类供体的HTL频率的系列分析,在正常情况下,人类外周血中的HTL频率显得相当稳定。这种LDA技术比混合淋巴细胞反应(MLR)更快速且信息更丰富,可能对移植受者的移植前评估和移植后供体反应性监测有用。